Connection
Megan Rech to Tissue Plasminogen Activator
This is a "connection" page, showing publications Megan Rech has written about Tissue Plasminogen Activator.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.789 |
|
|
|
-
Webb AJ, Brown CS, Rech MA. Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants and Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase. JAMA. 2022 06 21; 327(23):2354-2355.
Score: 0.627
-
Rech MA, Donahey E, DeMott JM, Coles LL, Peksa GD. The impact of antihypertensive use in the treatment of acute ischemic stroke in patients receiving alteplase. Am J Emerg Med. 2021 12; 50:93-96.
Score: 0.588
-
Rech MA, Bennett S, Donahey E. Pharmacist Participation in Acute Ischemic Stroke Decreases Door-to-Needle Time to Recombinant Tissue Plasminogen Activator. Ann Pharmacother. 2017 Dec; 51(12):1084-1089.
Score: 0.447
-
Garg R, Rech MA, Schneck M. Stroke Mimics: An Important Source of Bias in Acute Ischemic Stroke Research. J Stroke Cerebrovasc Dis. 2019 Sep; 28(9):2475-2480.
Score: 0.127